About ISAAR
Past ISAAR s
ISAAR 2007
ISAAR 2005
ISAAR 2003
ISAAR 2001
ISAAR 1999
ISAAR 1997
Photos of ISAAR
Past ISAARs
Select Year
ISAAR2007
ISAAR2005
ISAAR2003
ISAAR2001
ISAAR1999
ISAAR1997
ISAAR 1999
The 2nd International Symposium on Antimicrobial Resistance
May 7, 1999
Samsung Medical Center, Seoul, KOREA
Session I
Epidemiology and Mechanism of Drug Resistance(I)
Antimicrobial resistance on the horizon
•
Global crisis of pneumococcal resistance: alarm calls from the East
- Jae-Hoon Song
(Sungkyunkwan Univ., Korea)
•
Global Spread of Resistant Pneumococcal Clones : Nowhere to Hide
- Jae-Hoon Song (Sungkyunkwan Univ., Korea)
•
Glycopeptide-Resistant Enterococci : Clinical Perspectives
- Robin Patel (Mayo Clinic, USA)
•
Molecular Epidemiology Of Glycopeptide-Resistant Enterococci (GRE)
- Woo Joo Kim (Korea Univ., Korea)
•
Vancomycin-resistant
Staphylococcus aureus
(VRSA)
- Keiichi Hiramatsu (Juntendo Univ., Japan)
Session II
Epidemiology and Mechanism of Drug Resistance(II)
Mechanism of antimicrobial resistance
•
Beta - Lactamases & Extended - Spectrum Beta - Lactamases David Livermore (U.K)
•
Quinolone Resistance : More Than Topoisomerases
- Yeonhee Lee (Seoul Women's Univ., Korea)
Session III
State-of-the-art therapeutic strategy for resistant Gram-positive coccal infections
• Rabbit endocarditis model : Basis for novel antimicrobial regimens
- Walter R. Wilson (Mayo Clinic, USA)
•
Mice Model of Penicillin-Resistant Pneumococcal Pneumonia : Facts and Controversies
- Kazuhiro Tateda (Toho Univ., Japan)
Session IV
Preventive and Therapeutic Strategies in the Next Millennium(II)
Preventive strategies for resistant bacterial infections
•
Conjugate Vaccine Update Steve Black (Kaiser Permanente Medical Group, USA)
Session V
Preventive and Therapeutic Strategies in the Next Millennium(II)
Preventive strategies for resistant bacterial infections
•
Pharmacodynamicapproach to antimicrobial treatment for respiratory infections
- Michael R. Jacobs (Case Western Reserve Univ., USA)
• New quinolones and cephalosporines for resistant pneumococcal infections
- Walter R. Wilson (Mayo Clinic, USA)
•
New Antimicrobials for Glycopeptide - Resistant Infections
- Robin Patel (Mayo Clinic, USA)
Áß¾ÓÁ¤·Ä½Ã ½ºÅ©·Ñ µû¶ó´Ù´Ï´Â ·¹À̾î
About ARFID
| Newsletter Archive |
Sitemap
|
Contact us
Copyright ¨Ï ANSORP 2008. All Rights Reserved.